Cargando…
DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
BACKGROUND: Except for a few studies with contradictory observations, information is lacking on the possibility of association between DNA mismatch repair (MMR) status and the presence of cancer stem cells in colorectal carcinoma (CRC), two important aspects in colorectal carcinogenesis. METHODS: Ei...
Autores principales: | Cheah, Phaik-Leng, Li, Jing, Looi, Lai-Meng, Teoh, Kean-Hooi, Ong, Diana Bee-Lan, Arends, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138039/ https://www.ncbi.nlm.nih.gov/pubmed/30221090 http://dx.doi.org/10.7717/peerj.5530 |
Ejemplares similares
-
Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China
por: Zhang, Xiangyan, et al.
Publicado: (2018) -
REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial
por: King, A, et al.
Publicado: (2015) -
Meditation and yoga for irritable bowel syndrome: study protocol for a randomised clinical trial (MY-IBS study)
por: D'Silva, Adrijana, et al.
Publicado: (2022) -
A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma
por: Pang, Bing-yao, et al.
Publicado: (2022) -
Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a ‘real-world’ view
por: McFarlane, Michael, et al.
Publicado: (2016)